198 related articles for article (PubMed ID: 16716167)
21. Serum levels of GRO-α are elevated in association with disease activity in patients with Behçet's disease.
Kato Y; Yamamoto T
Int J Dermatol; 2012 Mar; 51(3):286-9. PubMed ID: 22348563
[TBL] [Abstract][Full Text] [Related]
22. MALDI-TOF/TOF-MS reveals elevated serum haptoglobin and amyloid A in Behcet's disease.
Mao L; Dong H; Yang P; Zhou H; Huang X; Lin X; Kijlstra A
J Proteome Res; 2008 Oct; 7(10):4500-7. PubMed ID: 18754684
[TBL] [Abstract][Full Text] [Related]
23. Serum interleukin-8 as a serologic marker of activity in Behçet's disease.
Gür-Toy G; Lenk N; Yalcin B; Aksaray S; Alli N
Int J Dermatol; 2005 Aug; 44(8):657-60. PubMed ID: 16101867
[TBL] [Abstract][Full Text] [Related]
24. Sister chromatid exchange and micronucleus studies in patients with Behçet's disease.
Karaman A; Kadi M; Kara F
J Cutan Pathol; 2009 Aug; 36(8):831-7. PubMed ID: 19159395
[TBL] [Abstract][Full Text] [Related]
25. Reduced levels of calcitonin gene-related peptide (CGRP) but not substance P during and after treatment of severe hypertension in man.
Edvinsson L; Ekman R; Thulin T
J Hum Hypertens; 1989 Aug; 3(4):267-70. PubMed ID: 2477545
[TBL] [Abstract][Full Text] [Related]
26. Serum cytokine profiles in Behçet's disease: is there a role for IL-15 in pathogenesis?
Curnow SJ; Pryce K; Modi N; Knight B; Graham EM; Stewart JE; Fortune F; Stanford MR; Murray PI; Wallace GR
Immunol Lett; 2008 Nov; 121(1):7-12. PubMed ID: 18706446
[TBL] [Abstract][Full Text] [Related]
27. Androgen receptor levels in the sebaceous glands of papulopustular lesions from patients with Behçet's disease and acne vulgaris: a controlled study.
Durusoy C; Alpsoy E; Elpek O; Karpuzoglu G
Adv Clin Path; 2002 Apr; 6(2):87-93. PubMed ID: 19753730
[TBL] [Abstract][Full Text] [Related]
28. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.
Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B
Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506
[TBL] [Abstract][Full Text] [Related]
29. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
[TBL] [Abstract][Full Text] [Related]
30. Effects of histamine H(2)-receptor antagonists on human plasma levels of calcitonin gene-related peptide, substance P and vasoactive intestinal peptide.
Itoh H; Naito T; Takeyama M
J Pharm Pharmacol; 2002 Nov; 54(11):1559-63. PubMed ID: 12495560
[TBL] [Abstract][Full Text] [Related]
31. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?
Keskin D; Keskin G; Inal A; Ozışık L
Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748
[TBL] [Abstract][Full Text] [Related]
32. Relationship between periodontal findings and specific polymorphisms of interleukin-1alpha and -1beta in Turkish patients with Behçet's disease.
Akman A; Ekinci NC; Kacaroglu H; Yavuzer U; Alpsoy E; Yegin O
Arch Dermatol Res; 2008 Jan; 300(1):19-26. PubMed ID: 17960403
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of interleukin-23 p19 mRNA in erythema nodosum-like lesions of Behçet's disease.
Lew W; Chang JY; Jung JY; Bang D
Br J Dermatol; 2008 Mar; 158(3):505-11. PubMed ID: 18205865
[TBL] [Abstract][Full Text] [Related]
34. Plasma changes of calcitonin gene-related peptide and substance P in patients with dialysis headache.
Alessandri M; Massanti L; Geppetti P; Bellucci G; Cipriani M; Fanciullacci M
Cephalalgia; 2006 Nov; 26(11):1287-93. PubMed ID: 17059435
[TBL] [Abstract][Full Text] [Related]
35. Serum lipoprotein (a) levels and Behçet's disease: is there an association?
Balik O; Gur G; Lenk N; Artuz F; Alli N
Int J Dermatol; 2007 Aug; 46(8):827-9. PubMed ID: 17651165
[TBL] [Abstract][Full Text] [Related]
36. Effects of calcitonin gene-related peptide on apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Liu C; Chen X; Jin Y; Qu R; Jiang PF; Wen GM; Tang ZH
Clin Exp Dermatol; 2007 Nov; 32(6):650-3. PubMed ID: 17725664
[TBL] [Abstract][Full Text] [Related]
37. Lack of association between leptin G2548A gene polymorphism and Behçet's disease.
Aydin F; Kara N; Senturk N; Gunes S; Canturk MT; Bagci H; Bek Y; Turanli AY
J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):68-71. PubMed ID: 17207170
[TBL] [Abstract][Full Text] [Related]
38. The role of selected neuropeptides in pathogenesis of atopic dermatitis.
Salomon J; Baran E
J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):223-8. PubMed ID: 18211417
[TBL] [Abstract][Full Text] [Related]
39. Enhanced interleukin 8 secretion in circulation of patients with Behçet's disease.
al-Dalaan A; al-Sedairy S; al-Balaa S; al-Janadi M; Elramahi K; Bahabri S; Siddiqui S
J Rheumatol; 1995 May; 22(5):904-7. PubMed ID: 8587080
[TBL] [Abstract][Full Text] [Related]
40. Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet's disease.
Turan B; Pfister K; Diener PA; Hell M; Möller B; Boyvat A; Ergin S; Villiger PM
Scand J Rheumatol; 2008; 37(2):135-41. PubMed ID: 18415772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
